Use of CCL1 in therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9352000
SERIAL NO

13696093

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of treating a medical condition in which suppression of effector T cells is beneficial in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of a CCL1 polypeptide, thereby treating the medical condition in the subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITEDHAIFA 3200004

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barsheshet, Yiftah Kfar-Tavor, IL 7 4
Karin, Nathan Haifa, IL 29 181
Wildbaum, Gizi Kiryat Yam, IL 21 101

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00